www.fdanews.com/articles/134528-delcath-8217-s-liver-cancer-treatment-device-suffers-regulatory-setback
Delcath’s Liver Cancer Treatment Device Suffers Regulatory Setback
February 23, 2011
Medical research firm Delcath Systems Inc. has suffered a setback in bringing its liver cancer treatment to market.
Post Star
Post Star